eCite Digital Repository
Smoking and COVID-19: what we know so far
Citation
Shastri, MD and Shukla, SD and Chong, WC and KC, R and Dua, K and Patel, RP and Peterson, GM and O'Toole, RF, Smoking and COVID-19: what we know so far, Respiratory Medicine, 176 Article 106237. ISSN 0954-6111 (2020) [Refereed Article]
Copyright Statement
Copyright 2020 Elsevier Ltd. All rights reserved
DOI: doi:10.1016/j.rmed.2020.106237
Abstract
The ongoing COVID-19 pandemic has placed a spotlight on infectious diseases and their associations with host factors and underlying conditions. New data on the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus are entering the public domain at a rapid rate such that their distillation often lags behind. To minimise weak associations becoming perceived as established paradigms, it is imperative that methodologies and outputs from different studies are appropriately critiqued and compared. In this review, we examine recent data on a potential relationship between smoking and COVID-19. While the causal role of smoking has been firmly demonstrated in regard to lung cancer and chronic obstructive pulmonary disease, such associations have the benefit of decades' worth of multi-centre epidemiological and mechanistic data. From our analysis of the available studies to date, it appears that a relationship is emerging in regard to patients with a smoking history having a higher likelihood of developing more severe symptoms of COVID-19 disease than non-smokers. Data on whether COVID-19 has a greater incidence in smokers than non-smokers is thus far, contradictory and inconclusive. There is therefore a need for some caution to be exercised until further research has been conducted in a wider range of geographical settings with sufficient numbers of patients that have been carefully phenotyped in respect of smoking status and adequate statistical control for confounding factors.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | Coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome, coronavirus 2 (SARS-CoV-2), smoking, angiotensin-converting-enzyme (ACE)-II, therapeutic targets |
| Research Division: | Health Sciences |
| Research Group: | Epidemiology |
| Research Field: | Disease surveillance |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Prevention of human diseases and conditions |
| UTAS Author: | Shastri, MD (Mr Madhur Shastri) |
| UTAS Author: | KC, R (Dr Rajendra KC) |
| UTAS Author: | Patel, RP (Dr Rahul Patel) |
| UTAS Author: | Peterson, GM (Professor Gregory Peterson) |
| UTAS Author: | O'Toole, RF (Dr Ronan O'Toole) |
| ID Code: | 141938 |
| Year Published: | 2020 |
| Web of Science® Times Cited: | 45 |
| Deposited By: | Pharmacy |
| Deposited On: | 2020-12-03 |
| Last Modified: | 2021-03-18 |
| Downloads: | 0 |
Repository Staff Only: item control page